Taylor Lindman

Extensive searches across SEC.gov, major news outlets, and recent reports through July 2026 confirm no credible new evidence or developments supporting the sensational Sept-Oct 2024 allegations of money laundering, insider trading, accounting fraud, or related charges against Coinbase, Kraken, or MicroStrategy. The 2025 dismissals with prejudice of core enforcement actions remain the dominant narrative, driven by the SEC's Crypto Task Force and broader enforcement rollback. A May 2025 NYT-reported probe into Coinbase user number disclosures persists without resolution updates, while MicroStrategy faces only private shareholder actions (one dismissed in 2025) and no SEC enforcement. In 2026, the Task Force under new Chief Counsel Taylor Lindman (appointed Feb 2026) focuses on rulemaking input rather than new probes. All original claims appear rooted in misdated or fabricated rumors.

2025 marked record-high lobbying expenditures by the pharmaceutical industry, with PhRMA spending nearly $38 million and total healthcare lobbying surging 16% to $653 million in the first three quarters, underscoring intensified influence amid regulatory shifts. Confirmed reverse revolving door appointments include Chainlink's Taylor Lindman as SEC Crypto Task Force Chief Counsel in February 2026 and Nancy Beck's ongoing senior role at EPA's chemical safety office; former Energy Secretary Jennifer Granholm expanded to Edison International's board alongside her DGA Group position. No major new forward revolving door placements for figures like ex-SEC Chair Gary Gensler as of March 2026, but the pattern persists with legislative efforts like H.R.3554 to curb it.